Arbutus Biopharma Corp Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2019-11-06: Form 10-Q; Exhibit 10.3; Description Offer Letter, dated August 8, 2019, by and between Arbutus Biopharma Corporation and Andrew Cheng..
- 2019-11-06: Form 10-Q; Exhibit 10.1; Description Form of Arbutus Biopharma Corporation Indemnity Agreement..
- 2019-08-05: Form 10-Q; Exhibit 10.9; Description Option Agreement, dated June 24, by and between Arbutus Biopharma, Inc. and William H. Collier.
- 2019-08-05: Form 10-Q; Exhibit 10.8; Description Form of Arbutus Biopharma Corporation Option Agreement.
| Filed | Form | Exhibit | Description |
|---|
| 2019-11-06 | 10-Q | 10.3 | Offer Letter, dated August 8, 2019, by and between Arbutus Biopharma Corporation and Andrew Cheng. |
|---|
| 2019-11-06 | 10-Q | 10.1 | Form of Arbutus Biopharma Corporation Indemnity Agreement. |
|---|
| 2019-08-05 | 10-Q | 10.9 | Option Agreement, dated June 24, by and between Arbutus Biopharma, Inc. and William H. Collier |
|---|
| 2019-08-05 | 10-Q | 10.8 | Form of Arbutus Biopharma Corporation Option Agreement |
|---|
| 2019-08-05 | 10-Q | 10.7 | Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan, as supplemented |
|---|
| 2019-08-05 | 10-Q | 10.6 | Purchase and Sale Agreement, dated July 2, 2019, by and between Arbutus Biopharma Corporation and OCM IP Healthcare Portfolio LP |
|---|
| 2019-08-05 | 10-Q | 10.5 | Executive Employment Agreement, dated July 10, 2015, by and between Arbutus Biopharma, Inc. and Michael McElhaugh, as amended by the First Amendment to Executive Employment Agreement, dated April 20, 2016, and the Second Amendment to Executive Employment Agreement dated December 11, 2018. |
|---|
| 2019-06-18 | 8-K | 10.4 | Form of Indemnity Agreement. |
|---|
| 2019-06-18 | 8-K | 10.3 | Employment Agreement, dated June 13, 2019, by and between Arbutus Biopharma Corporation and William H. Collier. |
|---|
| 2019-06-18 | 8-K | 10.2 | Consulting Agreement, dated June 13, 2019, by and between Arbutus Biopharma, Inc. and Mark J. Murray. |
|---|
| 2019-06-18 | 8-K | 10.1 | Separation Agreement and Release, dated June 13, 2019, by and between Arbutus Biopharma Corporation and Mark J. Murray. |
|---|
| 2019-05-06 | 10-Q | 10.1 | Koert VandenEnden Termination and Severance Agreement |
|---|
| 2019-03-07 | 10-K | 10.53 | Executive Signing Bonus, dated May 28, 2018, by and between the Company and David Hasting |
|---|
| 2019-03-07 | 10-K | 10.52 | Executive Employment Agreement, dated June 11, 2018, by and between the Company and David Hasting |
|---|
| 2019-03-07 | 10-K | 10.9 | Form of Indemnity Agreement (refiled herein with initial Agreement by reference to Exhibit 4.15 to the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2010 filed with the SEC on June 3, 2011). |
|---|